Reaction Details  Report a problem with these data
Target
Apoptosis regulator Bcl-2
Ligand
BDBM608724
Substrate
n/a
Meas. Tech.
BCL-2 TR-FRET Assay
IC50
<5±n/a nM
Citation
 Kysil, V; Parchinsky, VZ; Pushechnikov, A; Ivachtchenko, AV; Abagyan, R; Orry, A; Lam, PC; Savchuk, N Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors US Patent  US11697650 Publication Date 7/11/2023
Target
Name:
Apoptosis regulator Bcl-2
Synonyms:
Apoptosis regulator Bcl-2 Protein | B-cell lymphoma 2 protein (Bcl-2) | BCL-2 | BCL2 | BCL2_HUMAN | Bcl-2 Protein
Type:
Homodimer or heterodimer
Mol. Mass.:
26269.11
Organism:
Homo sapiens (Human)
Description:
P10415
Residue:
239
Sequence:
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK
  
Inhibitor
Name:
BDBM608724
Synonyms:
US11697650, Compound 1 | US11697650, Example 35
Type:
Small organic molecule
Emp. Form.:
C48H51N5O8
Mol. Mass.:
825.9472
SMILES:
COCCNC(=O)c1ccc(CN(C(=O)c2cc(-c3cc4OCOc4cc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n3CCCCc23)c2ccc(O)cc2)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: